InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: sharonc post# 128621

Monday, 05/21/2018 5:17:30 PM

Monday, May 21, 2018 5:17:30 PM

Post# of 426869

A poorly run study would have been stopped by the data monitoring committee


Absolutely false. DMC are not in the business of checking LtFu or Dropouts.

This could be done so the company could either feed off of any shred of positive data or stopped for futility for lack of evidence of any clinical benefit


Funny, none of this addresses topic of discussion, LtFu

AMRN would not have continued with this study and cost without a sense that they would succeed.


Based on this 'logic', 100% of studies would be successful, which is obviously false. How many studies ran until completion and failed?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News